75 related articles for article (PubMed ID: 17633459)
1. [Preparation and characterization of vincristine sulfate-loaded PLGA microspheres].
Chen HL; Chen H; Li XM; Yuan P; Zhang QQ
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2007 Jun; 29(3):342-6. PubMed ID: 17633459
[TBL] [Abstract][Full Text] [Related]
2. Stabilization of vinca alkaloids encapsulated in poly(lactide-co-glycolide) microspheres.
Marinina J; Shenderova A; Mallery SR; Schwendeman SP
Pharm Res; 2000 Jun; 17(6):677-83. PubMed ID: 10955840
[TBL] [Abstract][Full Text] [Related]
3. The study of improved controlled release of vincristine sulfate from collagen-chitosan complex film.
Chen H; Chen H; Liu L; Yuan P; Zhang Q
Artif Cells Blood Substit Immobil Biotechnol; 2008; 36(4):372-85. PubMed ID: 18649172
[TBL] [Abstract][Full Text] [Related]
4. Insulin loaded PLGA microspheres: effect of zinc salts on encapsulation, release, and stability.
Manoharan C; Singh J
J Pharm Sci; 2009 Feb; 98(2):529-42. PubMed ID: 18548615
[TBL] [Abstract][Full Text] [Related]
5. Development of novel self-assembled DS-PLGA hybrid nanoparticles for improving oral bioavailability of vincristine sulfate by P-gp inhibition.
Ling G; Zhang P; Zhang W; Sun J; Meng X; Qin Y; Deng Y; He Z
J Control Release; 2010 Dec; 148(2):241-8. PubMed ID: 20727928
[TBL] [Abstract][Full Text] [Related]
6. Improvement of survival in C6 rat glioma model by a sustained drug release from localized PLGA microspheres in a thermoreversible hydrogel.
Ozeki T; Kaneko D; Hashizawa K; Imai Y; Tagami T; Okada H
Int J Pharm; 2012 May; 427(2):299-304. PubMed ID: 22366485
[TBL] [Abstract][Full Text] [Related]
7. Preparation and in vitro evaluation of etoposide-loaded PLGA microspheres for pulmonary drug delivery.
Feng R; Zhang Z; Li Z; Huang G
Drug Deliv; 2014 May; 21(3):185-92. PubMed ID: 24107001
[TBL] [Abstract][Full Text] [Related]
8. Preparation and characterization of negatively charged poly(lactic-co-glycolic acid) microspheres.
Xu Q; Crossley A; Czernuszka J
J Pharm Sci; 2009 Jul; 98(7):2377-89. PubMed ID: 19009589
[TBL] [Abstract][Full Text] [Related]
9. Preparation and physicochemical characterization of T-OA PLGA microspheres.
Fu J; Dong XX; Zeng ZP; Yin XB; Li FW; Ni J
Chin J Nat Med; 2017 Dec; 15(12):912-916. PubMed ID: 29329648
[TBL] [Abstract][Full Text] [Related]
10. Stability of bovine serum albumin complexed with PEG-poly(L-histidine) diblock copolymer in PLGA microspheres.
Kim JH; Taluja A; Knutson K; Han Bae Y
J Control Release; 2005 Dec; 109(1-3):86-100. PubMed ID: 16266769
[TBL] [Abstract][Full Text] [Related]
11. Preparation, characterization, and in vitro evaluation of physostigmine-loaded poly(ortho ester) and poly(ortho ester)/poly(D,L-lactide-co-glycolide) blend microspheres fabricated by spray drying.
Wang L; Chaw CS; Yang YY; Moochhala SM; Zhao B; Ng S; Heller J
Biomaterials; 2004 Jul; 25(16):3275-82. PubMed ID: 14980422
[TBL] [Abstract][Full Text] [Related]
12. The characterization of paclitaxel-loaded microspheres manufactured from blends of poly(lactic-co-glycolic acid) (PLGA) and low molecular weight diblock copolymers.
Jackson JK; Hung T; Letchford K; Burt HM
Int J Pharm; 2007 Sep; 342(1-2):6-17. PubMed ID: 17555895
[TBL] [Abstract][Full Text] [Related]
13. Effect of medium-chain triglycerides on the release behavior of Endostar encapsulated PLGA microspheres.
Meng B; Li L; Hua S; Wang Q; Liu C; Xu X; Yin X
Int J Pharm; 2010 Sep; 397(1-2):136-43. PubMed ID: 20655370
[TBL] [Abstract][Full Text] [Related]
14. An Accelerated Release Method of Risperidone Loaded PLGA Microspheres with Good IVIVC.
Hu X; Zhang J; Tang X; Li M; Ma S; Liu C; Gao Y; Zhang Y; Liu Y; Yu F; Yang Y; Guo J; Li Z; Mei X
Curr Drug Deliv; 2018; 15(1):87-96. PubMed ID: 28521697
[TBL] [Abstract][Full Text] [Related]
15. Development of a novel morphological paclitaxel-loaded PLGA microspheres for effective cancer therapy: in vitro and in vivo evaluations.
Zhang Z; Wang X; Li B; Hou Y; Yang J; Yi L
Drug Deliv; 2018 Nov; 25(1):166-177. PubMed ID: 29299936
[TBL] [Abstract][Full Text] [Related]
16. Dual agents loaded PLGA nanoparticles: systematic study of particle size and drug entrapment efficiency.
Song X; Zhao Y; Hou S; Xu F; Zhao R; He J; Cai Z; Li Y; Chen Q
Eur J Pharm Biopharm; 2008 Jun; 69(2):445-53. PubMed ID: 18374554
[TBL] [Abstract][Full Text] [Related]
17. Formulation and characterization of injectable poly(DL-lactide-co-glycolide) implants loaded with N-acetylcysteine, a MMP inhibitor.
Desai KG; Mallery SR; Schwendeman SP
Pharm Res; 2008 Mar; 25(3):586-97. PubMed ID: 17891553
[TBL] [Abstract][Full Text] [Related]
18. Effects of process and formulation parameters on characteristics and internal morphology of poly(d,l-lactide-co-glycolide) microspheres formed by the solvent evaporation method.
Mao S; Shi Y; Li L; Xu J; Schaper A; Kissel T
Eur J Pharm Biopharm; 2008 Feb; 68(2):214-23. PubMed ID: 17651954
[TBL] [Abstract][Full Text] [Related]
19. PLGA nanoparticles simultaneously loaded with vincristine sulfate and verapamil hydrochloride: systematic study of particle size and drug entrapment efficiency.
Song X; Zhao Y; Wu W; Bi Y; Cai Z; Chen Q; Li Y; Hou S
Int J Pharm; 2008 Feb; 350(1-2):320-9. PubMed ID: 17913411
[TBL] [Abstract][Full Text] [Related]
20. Preparation, characterization and in vitro release study of BSA-loaded double-walled glucose-poly(lactide-co-glycolide) microspheres.
Ansary RH; Rahman MM; Awang MB; Katas H; Hadi H; Mohamed F; Doolaanea AA; Kamaruzzaman YB
Arch Pharm Res; 2016 Sep; 39(9):1242-56. PubMed ID: 26818028
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
